Elicio Therapeutics Inc. (ELTX) — Cash Flow Reinvestment Rate
Elicio Therapeutics Inc. (ELTX) has a Cash Flow Reinvestment Rate of 0.09x as of June 2022, reinvesting $559.00K (capex $559.00K ) from operating cash flow of $6.14 Million. Explore reinvestment intensity of Elicio Therapeutics Inc. to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Elicio Therapeutics Inc. Cash Flow Reinvestment Rate (2012–2013)
Historical reinvestment intensity for Elicio Therapeutics Inc. across 2 annual periods. Also explore total assets of Elicio Therapeutics Inc. for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Elicio Therapeutics Inc. (2012–2013)
Year-by-year capital reinvestment analysis for Elicio Therapeutics Inc.. For live market cap and broader valuation context, see how much is Elicio Therapeutics Inc. worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.01x | $17.57K | $1.89 Million | $17.57K | ▼ -79.3% |
| 2012 | 0.04x | $47.73K | $1.07 Million | $47.73K | — |